Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
CC transcript
MILLENNIUM PHARMACEUTICALS INC (MLNM) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/14/2008 8-K Quarterly results
04/15/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Deborah Dunsire",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Christophe Bianchi",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Marsha Fanucci",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Laurie Keating",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Nancy Simonian"
04/10/2008 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM ANNOUNCES VELCADE® FOR INJECTION FIRST-QUARTER 2008 U.S. NET SALES"
04/10/2008 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, among Takeda American Holdings, Inc., Mahogany Acquisition Corp. and Millennium Pharmaceuticals, Inc.",
"Amendment, to the Rights Agreement, between Millennium Pharmaceuticals, Inc. and Computershare Trust Company, N.A. (as successor Rights Agent to State Street Bank and Trust Company), as rights agent",
"TAKEDA TO ACQUIRE MILLENNIUM FOR US$25.00 PER SHARE IN AN ALL CASH TENDER OFFER VALUED AT $8.8 BILLION"
02/29/2008 8-K Regulation FD Disclosure
02/07/2008 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM OVER-DELIVERS ON 2007 GOALS AND FINANCIAL GUIDANCE"
01/04/2008 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM ANNOUNCES 2008 GOALS FOR GROWTH, BUILDING ON RECORD 2007 RESULTS"
11/01/2007 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM REPORTS OUTSTANDING THIRD-QUARTER RESULTS DRIVEN BY VELCADE FOR INJECTION SALES"
10/05/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/26/2007 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM HIGHLIGHTS STRONG SECOND-QUARTER RESULTS AND UPCOMING GROWTH CATALYSTS"
05/10/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Amendments to Article...
Docs: "Restated Certificate of Incorporation, as amended",
"Second Amended and Restated By-laws",
"2007 Incentive Plan",
"Form of Terms of Stock Option Granted Under 2007 Incentive Plan",
"Form of Restricted Stock Agreement Under 2007 Incentive Plan",
"Description of Non-Employee Director Compensation"
04/26/2007 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM REPORTS STRONG FINANCIAL AND OPERATIONAL RESULTS FOR FIRST QUARTER 2007"
03/13/2007 8-K Other Events
02/08/2007 8-K Results of Operations and Financial Condition, Departure of Directors or Principal Officers; Election of Directors; Appointme...
Docs: "MILLENNIUM EXCEEDS NON-GAAP PROFITABILITY GOAL AND NARROWS GAAP NET LOSS BY 78%"
01/04/2007 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM ACHIEVES 2006 NON-GAAP PROFITABILITY, REDUCES GAAP NET LOSS"
12/14/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
11/21/2006 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Indenture, between Millennium Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee, including the Form of Global Note attached as Exhibit A thereto",
"MILLENNIUM CLOSES SALE OF $250.0 MILLION IN CONVERTIBLE SENIOR NOTES"
11/13/2006 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Opinion of Wilmer Cutler Pickering Hale and Dorr LLP",
"Underwriting Agreement, among Millennium Pharmaceuticals, Inc. and the Underwriters named therein relating to the 2.25% Convertible Senior Notes due November 15, 2011",
"MILLENNIUM PRICES $225.0 MILLION IN CONVERTIBLE SENIOR NOTES"
11/09/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "MILLENNIUM ANNOUNCES PROPOSED OFFERING OF $200 MILLION IN CONVERTIBLE SENIOR NOTES"
11/03/2006 8-K Entry into a Material Definitive Agreement
10/30/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "MILLENNIUM AND ORTHO BIOTECH ENTER INTO U.S. CO-PROMOTION AGREEMENT FOR VELCADE® FOR INJECTION"
10/26/2006 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM ACHIEVES NON-GAAP PROFITABILITY AND REDUCES GAAP NET LOSS FOR THIRD CONSECUTIVE QUARTER"
10/17/2006 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Letter Agreement, effective as of October 17, 2006, among Millennium Pharmaceuticals, Inc., Sydney Acquisitions ULC and AnorMED Inc",
"Letter Agreement, effective as of October 17, 2006, among Millennium Pharmaceuticals, Inc., Sydney Acquisitions ULC and Specified Shareholders of AnorMED Inc"
10/02/2006 8-K Appointed a new director
Docs: "Support Agreement by and among Millennium Pharmaceuticals, Inc. and AnorMED Inc.",
"Shareholder Support Agreement by and among Millennium Pharmaceuticals, Inc. and Specified Shareholders of AnorMED Inc."
07/27/2006 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM REPORTS STRONG FINANCIAL RESULTS AND SIGNIFICANT ACCOMPLISHMENT TOWARD 2006 GOALS"
05/26/2006 8-K Entry into a Material Definitive Agreement
04/27/2006 8-K Results of Operations and Financial Condition
Docs: "MILLENNIUM ACHIEVES FIRST QUARTER 2006 NON-GAAP PROFITABILITY AND REDUCES GAAP NET LOSS"
03/08/2006 8-K Entry into a Material Definitive Agreement
02/10/2006 8-K Entry into a Material Definitive Agreement
02/06/2006 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Description of Success Sharing Bonus Program of Millennium Pharmaceuticals, Inc"
01/26/2006 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition
Docs: "MILLENNIUM ACHIEVES 2005 FINANCIAL GUIDANCE"
01/05/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "MILLENNIUM DETAILS STRATEGIC DRIVERS FOR PROFITABLE GROWTH AND 2006 GOALS; HIGHLIGHTS 2005 ACCOMPLISHMENTS"
11/14/2005 8-K Entry into a Material Definitive Agreement
10/26/2005 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition
Docs: "MILLENNIUM REPORTS STRONG THIRD QUARTER 2005 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy